These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 1320533)
41. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences]. Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005 [TBL] [Abstract][Full Text] [Related]
42. Oxidative mechanisms in nigral cell death in Parkinson's disease. Jenner P Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715 [TBL] [Abstract][Full Text] [Related]
43. Trichloroethylene and Parkinson's Disease: Risk Assessment. Liu M; Shin EJ; Dang DK; Jin CH; Lee PH; Jeong JH; Park SJ; Kim YS; Xing B; Xin T; Bing G; Kim HC Mol Neurobiol; 2018 Jul; 55(7):6201-6214. PubMed ID: 29270919 [TBL] [Abstract][Full Text] [Related]
44. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656 [TBL] [Abstract][Full Text] [Related]
45. The possible role of iron in the etiopathology of Parkinson's disease. Youdim MB; Ben-Shachar D; Riederer P Mov Disord; 1993; 8(1):1-12. PubMed ID: 8419792 [TBL] [Abstract][Full Text] [Related]
46. Neuronal cell loss of the striatonigral system in multiple system atrophy. Kume A; Takahashi A; Hashizume Y J Neurol Sci; 1993 Jul; 117(1-2):33-40. PubMed ID: 8410064 [TBL] [Abstract][Full Text] [Related]
47. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction. Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745 [TBL] [Abstract][Full Text] [Related]
48. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline). Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430 [TBL] [Abstract][Full Text] [Related]
49. Astrocytes and Parkinson's disease. Forno LS; DeLanney LE; Irwin I; Di Monte D; Langston JW Prog Brain Res; 1992; 94():429-36. PubMed ID: 1287728 [No Abstract] [Full Text] [Related]
50. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487 [TBL] [Abstract][Full Text] [Related]
51. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report. Hughes AJ; Daniel SE; Lees AJ Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453 [TBL] [Abstract][Full Text] [Related]
52. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409 [TBL] [Abstract][Full Text] [Related]
53. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
55. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
56. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Fu Y; Ito M; Fujita Y; Ito M; Ichihara M; Masuda A; Suzuki Y; Maesawa S; Kajita Y; Hirayama M; Ohsawa I; Ohta S; Ohno K Neurosci Lett; 2009 Apr; 453(2):81-5. PubMed ID: 19356598 [TBL] [Abstract][Full Text] [Related]
57. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease. Watson DL; Carpenter CL; Marks SS; Greenberg DA Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667 [TBL] [Abstract][Full Text] [Related]
59. Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease. Oiwa Y; Sanchez-Pernaute R; Harvey-White J; Bankiewicz KS J Neurosurg; 2003 Jan; 98(1):136-44. PubMed ID: 12546362 [TBL] [Abstract][Full Text] [Related]
60. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]